Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
18
ARMY.CX Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
-12.96%
Day range:
$0.04 - $0.04
52-week range:
$0.04 - $0.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.60x
Volume:
480K
Avg. volume:
505.5K
1-year change:
-76.47%
Market cap:
$2.8M
Revenue:
--
EPS (TTM):
-$0.07
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $84.6K | $1M | $456.7K | $481K | $349.1K | |
| Other Inc / (Exp) | -$130.3K | -- | -$822.9K | -$3M | -$54.8K | |
| Operating Expenses | $147.1K | $2.6M | $3.8M | $2.5M | $626.1K | |
| Operating Income | -$147.1K | -$2.6M | -$3.8M | -$2.5M | -$626.1K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$277.4K | -$10.7M | -$4.6M | -$5.5M | -$673.4K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$277.4K | -$10.7M | -$4.6M | -$5.5M | -$673.4K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$277.4K | -$10.7M | -$4.6M | -$5.5M | -$673.4K | |
| Basic EPS (Cont. Ops) | -$0.17 | -$2.22 | -$0.61 | -$0.50 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.17 | -$2.22 | -$0.61 | -$0.50 | -$0.05 | |
| Weighted Average Basic Share | $1.6M | $4.8M | $7.6M | $10.9M | $12.5M | |
| Weighted Average Diluted Share | $1.6M | $4.8M | $7.6M | $10.9M | $12.5M | |
| EBITDA | -$147.1K | -$2.6M | -$3.8M | -$2.5M | -$626.2K | |
| EBIT | -$147.1K | -$2.6M | -$3.8M | -$2.5M | -$626.2K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$147.1K | -$2.6M | -$3.8M | -$2.5M | -$626.1K | |
| Operating Income (Adjusted) | -$147.1K | -$2.6M | -$3.8M | -$2.5M | -$626.2K | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $735K | $81.5K | $67.2K | $52K | $102.3K | |
| Other Inc / (Exp) | -- | $102K | -$1.2M | $100 | -- | |
| Operating Expenses | $1.4M | $166.5K | $317.6K | $81K | $531.7K | |
| Operating Income | -$1.4M | -$166.5K | -$317.6K | -$81K | -$531.7K | |
| Net Interest Expenses | -- | $4K | -- | -- | $800 | |
| EBT. Incl. Unusual Items | -$1.4M | -$68.5K | -$1.5M | -$80.9K | -$532.1K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.3M | -$420.5K | -$1.5M | -$80.9K | -$532.1K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4M | -$68.5K | -$1.5M | -$80.9K | -$532.1K | |
| Basic EPS (Cont. Ops) | -$0.21 | -$0.01 | -$0.13 | -$0.01 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -$0.21 | -$0.01 | -$0.13 | -$0.01 | -$0.01 | |
| Weighted Average Basic Share | $6.5M | $7M | $11.1M | $11.2M | $45.3M | |
| Weighted Average Diluted Share | $6.5M | $7M | $11.1M | $11.2M | $45.3M | |
| EBITDA | -$1.4M | -$166.5K | -$317.6K | -$81K | -$531.7K | |
| EBIT | -$1.4M | -$166.5K | -$317.6K | -$81K | -$531.7K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$1.4M | -$166.5K | -$317.6K | -$81K | -$531.7K | |
| Operating Income (Adjusted) | -$1.4M | -$166.5K | -$317.6K | -$81K | -$531.7K | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.2M | $389.9K | $919.4K | $236.9K | $503.3K | |
| Other Inc / (Exp) | $200 | -$250K | -$1.7M | -$2M | -- | |
| Operating Expenses | $2.2M | $1.2M | $5.4M | $644.7K | $2M | |
| Operating Income | -$2.2M | -$1.2M | -$5.4M | -$644.7K | -$2M | |
| Net Interest Expenses | -- | $12K | -- | -- | $1.6K | |
| EBT. Incl. Unusual Items | -$2.2M | -$9.5M | -$7.2M | -$2.6M | -$2.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$10.2M | -$1.4M | -$7.1M | -$2.6M | -$2.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.2M | -$9.5M | -$7.2M | -$2.6M | -$2.3M | |
| Basic EPS (Cont. Ops) | -$0.47 | -$1.37 | -$0.71 | -$0.23 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.47 | -$1.37 | -$0.71 | -$0.23 | -$0.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$2.2M | -$1.2M | -$5.4M | -$644.7K | -$2M | |
| EBIT | -$2.2M | -$1.2M | -$5.4M | -$644.7K | -$2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2.2M | -$1.2M | -$5.4M | -$644.7K | -$2M | |
| Operating Income (Adjusted) | -$2.2M | -$1.2M | -$5.4M | -$644.7K | -$2M | |
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2026-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $394.5K | $462.8K | $218.5K | $372.8K | -- | |
| Other Inc / (Exp) | -$250K | -$1.1M | -$57.7K | -$316.7K | -- | |
| Operating Expenses | $654.8K | $2.2M | $406.5K | $1.8M | -- | |
| Operating Income | -$654.8K | -$2.2M | -$406.5K | -$1.8M | -- | |
| Net Interest Expenses | $12K | -- | -- | $1.6K | -- | |
| EBT. Incl. Unusual Items | -$916.8K | -$3.4M | -$457.7K | -$2.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$916.8K | -$3.4M | -$457.7K | -$2.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$916.8K | -$3.4M | -$457.7K | -$2.1M | -- | |
| Basic EPS (Cont. Ops) | -$0.13 | -$0.31 | -$0.04 | -$0.06 | -- | |
| Diluted EPS (Cont. Ops) | -$0.13 | -$0.31 | -$0.04 | -$0.06 | -- | |
| Weighted Average Basic Share | $20.9M | $32.4M | $33.6M | $118.3M | -- | |
| Weighted Average Diluted Share | $20.9M | $32.4M | $33.6M | $118.3M | -- | |
| EBITDA | -$654.8K | -$2.2M | -$406.5K | -$1.8M | -- | |
| EBIT | -$654.8K | -$2.2M | -$406.5K | -$1.8M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$654.8K | -$2.2M | -$406.5K | -$1.8M | -- | |
| Operating Income (Adjusted) | -$654.8K | -$2.2M | -$406.5K | -$1.8M | -- | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $262.4K | $1.1M | $1.3M | $248.8K | $116.9K | |
| Short Term Investments | -- | -- | $214.3K | $225K | -- | |
| Accounts Receivable, Net | $7.7K | $64.4K | $172.7K | $195.4K | $29.8K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $25.6K | $670.6K | $11.8K | $132.3K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $270.1K | $1.2M | $2.2M | $456K | $279K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $318.4K | $4M | $8.6M | $4M | $4.9M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $22K | $223.6K | $932.1K | $980.8K | $911.7K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22K | $223.6K | $932.1K | $980.8K | $911.7K | |
| Common Stock | $1M | $12.9M | $20.4M | $21.4M | $23M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $296.3K | $3.8M | $7.7M | $3M | $4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $296.4K | $3.8M | $7.7M | $3M | $4M | |
| Total Liabilities and Equity | $318.4K | $4M | $8.6M | $4M | $4.9M | |
| Cash and Short Terms | $262.4K | $1.1M | $1.3M | $248.8K | $116.9K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6M | $707.8K | $160.4K | $14.1K | $491.7K | |
| Short Term Investments | -- | $269.9K | $59.9K | -- | -- | |
| Accounts Receivable, Net | $52.1K | $122.9K | $192.5K | $17.5K | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $346.3K | $74.1K | $12.4K | $5K | $585.8K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2M | $904.9K | $365.3K | $36.6K | $1.2M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.4M | $4.7M | $5.9M | $3.5M | $5.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $41.6K | $1.5M | $793.3K | $920.8K | $998.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $41.6K | $1.5M | $793.3K | $920.8K | $998.3K | |
| Common Stock | $12.9M | $12.9M | $21.4M | $21.4M | $25.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.4M | $3.3M | $5.1M | $2.6M | $4.7M | |
| Total Liabilities and Equity | $4.4M | $4.7M | $5.9M | $3.5M | $5.7M | |
| Cash and Short Terms | $1.6M | $707.8K | $160.4K | $14.1K | $491.7K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$277.4K | -$10.7M | -$4.6M | -$5.5M | -$673.4K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $973.4K | $834.6K | $11.1K | |
| Change in Accounts Receivable | -$5.2K | -$64.4K | -$108.1K | -$22.9K | $165.6K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$146.4K | -$2.5M | -$2.8M | -$984.6K | -$490.3K | |
| Capital Expenditures | $40.7K | $1.2M | $2.4M | $709.7K | $128.4K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$40.7K | -$354.3K | -$1.9M | -$178.4K | $143.3K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $326.9K | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$108.5K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$105.5K | -- | $76.1K | |
| Cash From Financing | $447.4K | $4M | $4.5M | -- | $456.1K | |
| Beginning Cash (CF) | $262.4K | $1.1M | $1.1M | $23.8K | $116.9K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $260.4K | $1.1M | -$4.7K | -$1.1M | $93.1K | |
| Ending Cash (CF) | $522.8K | $2.3M | $1.3M | -$1M | $194.1K | |
| Levered Free Cash Flow | -$187.1K | -$3.7M | -$5.2M | -$1.7M | -$618.7K | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.3M | -$420.5K | -$1.5M | -$80.9K | -$532.1K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | $65K | |
| Change in Accounts Receivable | -$27K | -$37.8K | -$7.3K | -$2.3K | -$39.3K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.1M | -$26K | -$118.4K | -$47.5K | -$678.2K | |
| Capital Expenditures | $819K | $1.9M | $533.9K | -- | -$3.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$610.8K | $19.5K | -$1.2M | -- | $103.1K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2.2M | $385K | -- | -- | $747.1K | |
| Beginning Cash (CF) | $1.6M | $437.9K | $100.5K | $14.1K | $191.7K | |
| Foreign Exchange Rate Adjustment | -- | -- | $31.2K | -$2.1K | -$3.1K | |
| Additions / Reductions | -$543.3K | $378.5K | -$1.3M | -$49.6K | $168.9K | |
| Ending Cash (CF) | $1.1M | $816.4K | -$1.1M | -$37.5K | $357.5K | |
| Levered Free Cash Flow | -$2.9M | -$1.9M | -$652.3K | -$47.5K | -$675.1K | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.2M | -$1.4M | -$7.1M | -$2.6M | -$2.3M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $1.8M | -- | $464.9K | |
| Change in Accounts Receivable | -$39.6K | -$85.7K | -$69.6K | $175K | -$58.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.5M | -$109.5K | -$3.7M | -$319K | -$2.1M | |
| Capital Expenditures | $850.9K | $2.3M | $1.1M | $115.7K | $131.6K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.4K | -$1.8M | -$591.1K | $170.6K | -$31.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $4.3M | $667.4K | $3.8M | -- | $2.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8M | -$1.2M | -$348K | -$86.4K | $177.5K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$3.4M | -$2.4M | -$4.8M | -$434.7K | -$2.2M | |
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2026-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$916.8K | -$3.4M | -$457.7K | -$2.1M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $834.6K | -- | $453.8K | -- | |
| Change in Accounts Receivable | -$58.5K | -$20K | $177.9K | -$46.1K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$31.1K | -$935.1K | -$269.6K | -$1.8M | -- | |
| Capital Expenditures | $1.9M | $614.1K | $20K | $23.2K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.4M | -$97.1K | $251.7K | $76.8K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $322.4K | -- | -- | $50K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$102.3K | -- | |
| Cash From Financing | $732.4K | -- | -- | $1.8M | -- | |
| Beginning Cash (CF) | $1.4M | $2.3M | $88.2K | $284.7K | -- | |
| Foreign Exchange Rate Adjustment | -- | $4.1K | $8.2K | -$6K | -- | |
| Additions / Reductions | -$684.8K | -$1M | -$9.7K | $74.8K | -- | |
| Ending Cash (CF) | $748.5K | $1.3M | $86.9K | $353.6K | -- | |
| Levered Free Cash Flow | -$2M | -$1.5M | -$289.6K | -$1.9M | -- | |
Related Companies
Get ARMY.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARMY.CX
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
0.60x
--
Price / LTM sales
--
--
Growth Metrics
ARMY.CX
Sector
Revenue growth
--
--
Earnings growth
-63.89%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
ARMY.CX
Sector
Profitability FY 2024
--
--
Return on invested capital
-59.79%
--
Return on assets
-49.02%
--
Return on equity
-60.45%
--
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
ARMY.CX
Sector
Total cash
$491.7K
--
Short term investments
--
--
Total assets
$4.9M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
